Atul Pande - Feb 1, 2022 Form 4 Insider Report for Karuna Therapeutics, Inc. (KRTX)

Role
Director
Signature
/s/ Troy Ignelzi, Attorney-in-Fact
Stock symbol
KRTX
Transactions as of
Feb 1, 2022
Transactions value $
-$237,000
Form type
4
Date filed
2/2/2022, 03:08 PM
Previous filing
Jan 12, 2022
Next filing
Jun 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRTX Common Stock Options Exercise $40K +2.5K $16.00* 2.5K Feb 1, 2022 Direct
transaction KRTX Common Stock Sale -$277K -2.5K -100% $110.80 0 Feb 1, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRTX Option (right to buy) Options Exercise $0 -2.5K -100% $0.00* 0 Feb 1, 2022 Common Stock 2.5K $16.00 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 1, 2021.